The Biden administration has purchased an additional 50 million Pfizer-BioNTech COVID-19 vaccine doses for children to be delivered by the end of April next year, the drugmakers said in a statement on Thursday.
“The U.S. will receive these additional doses to continue to support preparedness for pediatric vaccinations, including securing vaccines for children under 5 years of age, should they receive regulatory authorization,” Pfizer-BioNTech said in a press release.
